New treatment option for Diabetes Mellitus
Official title Improving Patient-centered Care for Diabetes in Bangladesh Through "Dynamic Integration" of Vision Care on the Demand Side
ClinicalTrials.gov ID: NCT06968611
What this study is testing
- What it's testing
- The goal of this clinical trial is to determine whether there is an increase in participant uptake of diabetes mellitus (DM) and diabetic retinopathy (DR) services and improved quality of patient-centered diabetic care resulting from the use of automated voice message reminders to sensitize people with DM about the potential for sight loss alongside the provision of free reading glasses. The main questions it aims to answer are: 1.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 and older
You may be able to join if
- Diagnosed with DM within the last 6 months
- Over 30 years of age
- Currently treated at the Dinajpur Diabetes Hospital
- Possess a mobile phone to receive voice messages
- Willingness to participate in the study, and ability to give informed consent
You likely can't join if
- Other significant causes of vision loss
- Medical conditions that could impair compliance with follow-up (such as stroke, dementia, etc.)
The study team makes the final eligibility decision.
Where it's taking place
- Dinajpur, Bangladesh
- Dinajpur Sadar, Bangladesh
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 30 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dinajpur, Bangladesh; Dinajpur Sadar, Bangladesh. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.